Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87% Market Closed
Market Cap: 12.5B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Cash Flow Statement

Cash Flow Statement
Calliditas Therapeutics AB

Rotate your device to view
Cash Flow Statement
Currency: SEK
Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
(85)
(112)
(114)
(128)
(132)
(137)
(33)
(55)
(28)
(58)
(210)
(262)
(380)
(458)
(551)
(438)
(524)
(582)
(632)
(677)
(422)
(394)
(259)
(382)
(373)
(397)
(353)
Depreciation & Amortization
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
13
0
0
0
49
0
0
Other Non-Cash Items
0
0
0
0
0
0
1
1
0
3
4
8
15
20
29
34
67
67
72
73
48
83
62
109
54
92
195
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
4
4
7
7
7
9
20
22
23
22
25
Cash Interest Paid
0
0
0
0
0
0
3
0
0
0
(3)
0
0
0
0
1
5
11
16
29
35
45
58
64
94
106
112
Change in Working Capital
16
22
0
16
4
(7)
(134)
(15)
(45)
14
158
20
55
13
32
(16)
(4)
(4)
(50)
(99)
49
(42)
(93)
46
(164)
(96)
(86)
Cash from Operating Activities
(68)
N/A
(89)
-31%
(114)
-28%
(112)
+1%
(128)
-14%
(144)
-12%
(166)
-16%
(68)
+59%
(71)
-4%
(40)
+43%
(48)
-19%
(235)
-387%
(309)
-32%
(425)
-37%
(490)
-16%
(420)
+14%
(462)
-10%
(519)
-12%
(611)
-18%
(703)
-15%
(311)
+56%
(352)
-13%
(290)
+18%
(227)
+21%
(435)
-91%
(401)
+8%
(245)
+39%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
0
0
0
(16)
0
0
0
0
0
0
0
(23)
0
0
0
(3)
0
0
0
(13)
0
0
Other Items
(0)
(0)
(0)
(0)
0
0
(2)
(18)
(2)
(18)
(16)
(0)
(173)
(173)
(191)
(192)
(2)
(27)
(8)
(9)
(3)
(5)
(6)
(13)
(1)
(15)
(14)
Cash from Investing Activities
(0)
N/A
(0)
N/A
(0)
N/A
(0)
N/A
0
N/A
0
N/A
(2)
N/A
(18)
-786%
(18)
-2%
(18)
N/A
(16)
+11%
(0)
+98%
(173)
-58 810%
(173)
0%
(191)
-11%
(192)
0%
(24)
+87%
(27)
-10%
(8)
+69%
(9)
-8%
(5)
+43%
(5)
-5%
(6)
-17%
(13)
-103%
(14)
-7%
(15)
-7%
(14)
+7%
Financing Cash Flow
Net Issuance of Common Stock
3
0
0
0
741
0
0
0
213
0
0
946
951
951
951
328
324
386
388
64
95
33
31
31
0
0
0
Net Issuance of Debt
36
0
0
0
(0)
0
0
0
(2)
0
0
(2)
(4)
(5)
(5)
180
179
178
413
227
481
480
243
242
200
197
196
Other
62
131
95
776
(24)
687
686
202
(13)
185
977
(97)
(178)
(173)
(965)
(111)
(68)
(59)
(59)
(39)
(0)
0
0
0
(0)
0
0
Cash from Financing Activities
101
N/A
131
+29%
95
-27%
776
+715%
717
-8%
687
-4%
686
0%
202
-71%
199
-2%
185
-7%
977
+427%
847
-13%
769
-9%
772
+1%
(19)
N/A
397
N/A
435
+10%
505
+16%
741
+47%
252
-66%
576
+129%
513
-11%
274
-47%
274
0%
200
-27%
197
-1%
196
-1%
Change in Cash
Effect of Foreign Exchange Rates
(0)
(0)
(0)
(0)
0
1
0
3
(2)
5
12
(20)
(44)
(36)
(49)
(18)
10
(1)
16
32
34
33
41
17
(27)
15
(6)
Net Change in Cash
33
N/A
41
+25%
(19)
N/A
664
N/A
589
-11%
544
-8%
518
-5%
119
-77%
107
-10%
132
+23%
925
+602%
592
-36%
243
-59%
139
-43%
(750)
N/A
(233)
+69%
(41)
+82%
(42)
-3%
137
N/A
(428)
N/A
294
N/A
188
-36%
19
-90%
51
+162%
(275)
N/A
(203)
+26%
(69)
+66%
Free Cash Flow
Free Cash Flow
(68)
N/A
(89)
-31%
(114)
-28%
(112)
+1%
(128)
-14%
(144)
-12%
(166)
-16%
(68)
+59%
(87)
-28%
(40)
+54%
(48)
-19%
(235)
-387%
(309)
-32%
(425)
-37%
(490)
-16%
(420)
+14%
(484)
-15%
(519)
-7%
(611)
-18%
(703)
-15%
(314)
+55%
(352)
-12%
(290)
+18%
(227)
+21%
(447)
-97%
(401)
+10%
(245)
+39%

See Also

Discover More